Mediators and nonsteroid antiinflammatory drugs in immunologically specific and nonspecific inflammatory processes.
D000276:Adjuvants, Immunologic; D000632:Aminopyrine / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use* / Q000633:toxicity; D001168:Arthritis / Q000188:drug therapy; D001920:Bradykinin / Q000494:pharmacology; D002738:Chloroquine / Q000627:therapeutic use; D003877:Dermatitis, Contact / Q000188:drug therapy; D004336:Drug Antagonism; D006168:Guinea Pigs; D006632:Histamine / Q000494:pharmacology; D006968:Hypersensitivity, Delayed / Q000188:drug therapy; D007154:Immune System Diseases / Q000188:drug therapy; D007213:Indomethacin / Q000627:therapeutic use; D007249:Inflammation / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D051379:Mice; D010653:Phenylbutazone / Q000627:therapeutic use; D011817:Rabbits; D051381:Rats; D012459:Salicylates / Q000627:therapeutic use; D012701:Serotonin / Q000494:pharmacology; D016038:Skin Transplantation; D014181:Transplantation Immunology / Q000187:drug effects; D014184:Transplantation, Homologous; D014992:Xylenes / Q000009:adverse effects
D000276:Adjuvants, Immunologic; D000893:Anti-Inflammatory Agents; D012459:Salicylates; D014992:Xylenes; D000632:Aminopyrine; D012701:Serotonin; D006632:Histamine; D002738:Chloroquine; D010653:Phenylbutazone; D001920:Bradykinin; D007213:Indomethacin